PMV Pharmaceuticals is a clinical-stage precision oncology company focusing on developing targeted therapies for patients with genomically defined cancers. The company’s innovative approach uses its proprietary discovery platform to identify and develop small molecule inhibitors of p53 mutations, a commonly occurring genetic mutation in cancer cells. With a commitment to improving patient outcomes, PMV Pharmaceuticals aims to transform cancer treatment through precision medicine.
